Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Grace Cui"'
Autor:
Nalinikanth Kotagiri, Matthew L. Cooper, Michael Rettig, Christopher Egbulefu, Julie Prior, Grace Cui, Partha Karmakar, Mingzhou Zhou, Xiaoxia Yang, Gail Sudlow, Lynne Marsala, Chantiya Chanswangphuwana, Lan Lu, LeMoyne Habimana-Griffin, Monica Shokeen, Xinming Xu, Katherine Weilbaecher, Michael Tomasson, Gregory Lanza, John F. DiPersio, Samuel Achilefu
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Most of the systemic cancer therapies lack spatiotemporal control. Here, the authors show targeted activation of a light-sensitive drug by radiopharmaceuticals in disseminated cancer cells as potential in vivo treatment of metastatic diseases with re
Externí odkaz:
https://doaj.org/article/26f55b0e68cc493ba96ad8ac0b602bc1
Autor:
Dolonchampa Maji, Jin Lu, Pinaki Sarder, Anne H. Schmieder, Grace Cui, Xiaoxia Yang, Dipanjan Pan, Matthew D. Lew, Samuel Achilefu, Gregory M. Lanza
Publikováno v:
Precision Nanomedicine, Vol 1, Iss 2 (2018)
While the in vivo efficacy of Sn-2 phosphatidylcholine prodrugs incorporated into targeted, non-pegylated lipid-encapsulated nanoparticles was demonstrated in prior preclinical studies, the microscopic details of cell prodrug internalization and traf
Externí odkaz:
https://doaj.org/article/ab191da79cdc46a68915263e5bac6314
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Felicia Siew Kay Ng, Jie Hong Chiang, Grace Cui Fang Ng, Cheryl Si Hui Lee, Christiani Jeyakumar Henry
Publikováno v:
International Journal of Food Science & Technology.
Autor:
Michael H. Tomasson, Gregory M. Lanza, Edward V. Prochownik, Katherine N. Weilbaecher, Lan Lu, Xiaoxia Yang, Angana Senpan, Grace Cui, Dipanjan Pan, Deepti Soodgupta
Supplemental Figures 1-4. Supplemental figure 1: Representative schematic of lipid encapsulated nanoparticle design. Supplemental figure 2: The pharmacokinetics nanoparticles Supplemental figure 3:Biodistribution of the Nanoparticles Supplemental fig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b98f4f8e9f2ca4146ad72ad6b6ee016
https://doi.org/10.1158/1535-7163.22500501.v1
https://doi.org/10.1158/1535-7163.22500501.v1
Autor:
Michael H. Tomasson, Gregory M. Lanza, Edward V. Prochownik, Katherine N. Weilbaecher, Lan Lu, Xiaoxia Yang, Angana Senpan, Grace Cui, Dipanjan Pan, Deepti Soodgupta
Multiple myeloma pathogenesis is driven by the MYC oncoprotein, its dimerization with MAX, and the binding of this heterodimer to E-Boxes in the vicinity of target genes. The systemic utility of potent small molecule inhibitors of MYC-MAX dimerizatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::172b44d5be812023c666c65927e1fce7
https://doi.org/10.1158/1535-7163.c.6536481
https://doi.org/10.1158/1535-7163.c.6536481
Autor:
Gregory M. Lanza, John F. DiPersio, Ravi Vij, Steven Fletcher, Kathleen Simons, Michael Rettig, Julie Ritchey, Anne H. Schmieder-Atteberry, Julie O'Neal, Mark A. Fiala, Noriko Yanaba, Dipanjan Pan, Grace Cui, Xiaoxia Yang, John S. Allen, Michael J. Scott, Francesca Fontana
Supplemental figure 4 Color
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a6cf4f3e32d2b54810a6097190af6c
https://doi.org/10.1158/1078-0432.22480217.v1
https://doi.org/10.1158/1078-0432.22480217.v1
Autor:
Gregory M. Lanza, John F. DiPersio, Ravi Vij, Steven Fletcher, Kathleen Simons, Michael Rettig, Julie Ritchey, Anne H. Schmieder-Atteberry, Julie O'Neal, Mark A. Fiala, Noriko Yanaba, Dipanjan Pan, Grace Cui, Xiaoxia Yang, John S. Allen, Michael J. Scott, Francesca Fontana
Supplemental Figure 3 Color
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea6dea6cfabac5468683022d1f197cf
https://doi.org/10.1158/1078-0432.22480220
https://doi.org/10.1158/1078-0432.22480220
Autor:
Gregory M. Lanza, John F. DiPersio, Ravi Vij, Steven Fletcher, Kathleen Simons, Michael Rettig, Julie Ritchey, Anne H. Schmieder-Atteberry, Julie O'Neal, Mark A. Fiala, Noriko Yanaba, Dipanjan Pan, Grace Cui, Xiaoxia Yang, John S. Allen, Michael J. Scott, Francesca Fontana
Purpose:In multiple myeloma, drug-resistant cells underlie relapse or progression following chemotherapy. Cell adhesion–mediated drug resistance (CAM-DR) is an established mechanism used by myeloma cells (MMC) to survive chemotherapy and its marker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae8e112556f8acd02434878b5fdf8f4f
https://doi.org/10.1158/1078-0432.c.6530396
https://doi.org/10.1158/1078-0432.c.6530396